Search results
BioNTech gets $145 million funding for African vaccine plants
Reuters via AOL· 13 hours agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants
Reuters· 13 hours agoCOVID-19 vaccine maker BioNTech won up to $145 million in funding from a global coalition against...
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
Endpoints News· 2 days agoAs BioNTech’s pipeline tilts back toward oncology, the German biotech is once again tapping a young...
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 4 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund ...
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 6 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
Germany's military to drop mandatory Covid-19 vaccination requirement
dpa international via Yahoo News· 13 hours agoSoldiers in the German armed forces will no longer be required to present proof of coronavirus...
BioNTech pays $25M upfront to strengthen ADC bond with China's MediLink
FierceBiotech· 2 days agoAfter penning a couple of antibody-drug conjugate (ADC) deals in 2023, BioNTech has returned to MediLink Therapeutics to further pad out its portfolio. This time,
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 6 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock. This is an increase ...
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement...
WKBN 27 Youngstown· 3 days agoMediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "< ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 6 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...